Bridget Hurley

Bridget is the Clinical Development Lead at Verily Life Sciences. She has over 20 years of US and International experience in medical device product development and clinical and regulatory affairs. Prior to joining Verily, Bridget was the VP of clinical and regulatory for Evidation, a digital health company conducting real-world evidence studies. Bridget has held leadership positions across R&D and clinical at Guidant and Abbott – playing key roles in the development and commercialization of the XIENCE V drug-eluting stent and the MitraClip mitral valve repair system. After the MitraClip system received FDA approval, Bridget worked with early stage medtech companies as the head of clinical and regulatory for Element Science and Pulmonx. Bridget holds BS and MS degrees in Mechanical Engineering from The University of Texas and Georgia Tech.